15289-s-bos

8 139 | Novel protein biomarker predictors of CAD in FH References 1. Austin MA, Hutter CM, Zimmern RL and Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol . 2004;160:407-20. 2. Austin MA, Hutter CM, Zimmern RL and Humphries SE. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol . 2004;160:421-9. 3. Ademi Z, Watts GF, Juniper A and Liew D. A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia. Int J Cardiol . 2013;167:2391-6. 4. Brown MS and Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science . 1986;232:34-47. 5. Rader DJ, Cohen J and Hobbs HH. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest . 2003;111:1795-803. 6. Soutar AK and Naoumova RP. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med . 2007;4:214-25. 7. Umans-Eckenhausen MA, Sijbrands EJ, Kastelein JJ and Defesche JC. Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation . 2002;106:3031-6. 8. Pijlman AH, Huijgen R, Verhagen SN, Imholz BP, Liem AH, Kastelein JJ, Abbink EJ, Stalenhoef AF and Visseren FL. Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands. Atherosclerosis . 2010;209:189-94. 9. Neefjes LA, Ten Kate GJ, Alexia R, Nieman K, Galema-Boers AJ, Langendonk JG, Weustink AC, Mollet NR, Sijbrands EJ, Krestin GP and de Feyter PJ. Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia. Atherosclerosis . 2011;219:721-7. 10. Vuorio A, Docherty KF, Humphries SE, Kuoppala J and Kovanen PT. Statin treatment of children with familial hypercholesterolemia--trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus? Atherosclerosis . 2013;226:315-20. 11. Benn M, Watts GF, Tybjaerg-Hansen A and Nordestgaard BG. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab . 2012;97:3956-64. 12. Versmissen J, Oosterveer DM, Yazdanpanah M, Defesche JC, Basart DC, Liem AH, Heeringa J, Witteman JC, Lansberg PJ, Kastelein JJ and Sijbrands EJ. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ . 2008;337:a2423. 13. Polonsky TS and Greenland P. CVD screening in low-risk, asymptomatic adults: clinical trials needed. Nature reviews Cardiology . 2012;9:599-604. 14. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE, Jr., Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O’Donnell CJ, Smith SC, Jr., Wilson PW, American Heart Association Expert Panel on Subclinical Atherosclerotic D, Emerging Risk F and the Stroke C. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation . 2009;119:2408-16. 15. Kristensen LP, Larsen MR, Mickley H, Saaby L, Diederichsen AC, Lambrechtsen J, Rasmussen LM and Overgaard M. Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin. J Proteomics . 2014;101:141-53. 16. Datta A, Chen CP and Sze SK. Discovery of prognostic biomarker candidates of lacunar infarction by quantitative proteomics of microvesicles enriched plasma. PLoS One . 2014;9:e94663. 17. Zieske LR. A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot . 2006;57:1501-8. 18. van den Oord SC, Sijbrands EJ, ten Kate GL, van Klaveren D, van Domburg RT, van der Steen AF and Schinkel AF. Carotid intima-media thickness for cardiovascular risk assessment: systematic review and meta-analysis. Atherosclerosis . 2013;228:1-11. 19. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr. and Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol . 1990;15:827-32.